Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To compare the efficacy and safety of rho kinase inhibitors to placebo or other glaucoma medication in people diagnosed with open-angle glaucoma or ocular hypertension.
Bibliographical noteFunding Information:
Thank you to the Cochrane Eyes and Vision (CEV) Information Specialist, who created and will execute the electronic search strategies. We thank Renee F. Wilson from CEV@US for her helpful feedback. We thank the following peer reviewers for their feedback: Renee Bovelle (Howard University) and Anthony King (Spire Nottingham Hospital). This protocol was managed by CEV@US and was signed off for publication by Tianjing Li and Richard Wormald.
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Copyright 2021 Elsevier B.V., All rights reserved.
ASJC Scopus subject areas
- Pharmacology (medical)